Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lometrexol and Folic Acid in Previously Treated Advanced NSCLC
NCT00033722Phase 2Unknown
- Sponsor
- Tularik Inc.
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lometrexol in non-small cell lung cancer (NSCLC), sponsored by Tularik Inc.. Status: unknown.
02
Drugs
lometrexol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00033722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033722.